跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VENLAFAXINA RETARD RATIO 75 MG CAPSULAS DURAS DE LIBERACION PROLONGADA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
VENLAFAXINA RETARD RATIO 75 MG CAPSULAS DURAS DE LIBERACION PROLONGADA
Approved
STANDARD
VENLAFAXINA RETARD RATIO 75 MG CAPSULAS DURAS DE LIBERACION PROLONGADA
Ratiopharm Espana S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 1, 2022
Approval ID
a068c60de278f6c4
Company
Ratiopharm Espana S.A.
Type
Standard
Approval Details
Approval Id
a068c60de278f6c4
Drug Cima Aemps Name
VENLAFAXINA RETARD RATIO 75 MG CAPSULAS DURAS DE LIBERACION PROLONGADA
Register Number
87918
Holder Company Name
Ratiopharm Espana S.A.
Marketing Company Name
Ratiopharm Espana S.A.
Authorization Date
2022-07-01
Dosage Form
CÁPSULA DURA DE LIBERACIÓN PROLONGADA
Dose
75 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Ratiopharm Espana S.A.
Active Ingredients
VENLAFAXINA HIDROCLORURO
85,25 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 1, 2022
Approval ID
a068c60de278f6c4
Type
Standard
Back to CIMA-AEMPS Approvals